Thermo Fisher simplifies UV-Vis spectroscopy

Published: 26-Aug-2010
Manufacturing Analysis

Evolution 200 series streamlines QA/QC processes

Thermo Fisher Scientific has introduced the Evolution 200 series of UV-Visible spectrophotometers featuring Insight software with CUE (Customised User Environment) scripting capabilities, enabling the operator to simplify workflow.

There are three instruments in the series for applications ranging from standard quantitative analysis to research life science assays. They are for routine QA/QC analyses in the life science, food and beverage and material science industries as well as offering fast data collection rates for kinetics measurements (up to 100 data points/sec).

The Evolution 200 instruments feature high quality accessories and application-specific technology to meet sampling needs.

Innovative Smart accessories enable accurate, cost-effective sample handling with automated software recognition and programmable control. Adding temperature control and fibre optic accessories can increase the instrument’s productivity and extend sampling options.

In addition, the Evolution 220 and Evolution 260 Bio feature Application Focused Beam Geometry (AFBG) technology that tailors the instrument’s optical system to specific applications for micro-cells, solid sampling and fibre optics.

The Evolution 260 Bio includes enhanced Insight life science software, offering pre-programmed assay methods for increased accuracy and convenience.

The software’s data browser feature allows users to preview a thumbnail of results before opening the file and to sort by workbook type, file name and date. In addition, the workbook format helps organise data, method and accessory options by saving them all in one place. The workbook can be reopened to continue capturing data using the same instrument configuration, saving time and improving the accuracy of results.

  • Companies:
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

Read more
New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US
Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases
Manufacturing

Thermo Fisher's Accelerator CDMO and CRO solutions can slash drug development times by 3 years, study finds

The centralised solution can streamline the drug development process, facilitating the rapid commercialisation of new therapeutics
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating therapeutic manufacturing with smart and sustainable technologies

In this article, John Puglia, Senior Director of Research and Development, Single-Use Technologies, at Thermo Fisher Scientific, explores how innovative technologies are revolutionising biomanufacturing for a smarter, more sustainable future
Manufacturing

Ethris and Thermo Fisher Scientific to provide mRNA technology to biopharma market

Ethris will combine its mRNA technology platforms with Thermo Fisher's GMP manufacturing capacity to serve the biopharmaceutical market
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Unlocking the secrets of cells: the revolutionary power of spatial biology

Spatial biology is the study of biomolecules and cells within their native tissue microenvironment. This approach has enabled scientists to develop a better understanding of cell interactions in their natural locations
Manufacturing

Thermo Fisher Scientific to invest $2bn into US manufacturing capabilities

The life science service provider will put 75% of the $2bn into its US pharmaceutical manufacturing capacities, helping to produce key medicines for the market
Subscribe now